HelixNano Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 48

HelixNano General Information

Description

Operator of a native biotechnology company intended to enable previously impossible applications across human and non-human biology. The company's platform uses artificial intelligence to leverage synthetic biology to safely and reliably express transgenes in humans for next-generation gene therapies, genome engineering, and beyond, allowing clinicians to treat patients suffering from various diseases.

Contact Information

Website
www.helixnano.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Channel Center Street
  • Suite 600
  • Boston, MA 02210
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Nanotechnology, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 5 Channel Center Street
  • Suite 600
  • Boston, MA 02210
  • United States

HelixNano Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HelixNano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 16-May-2024 Completed Pre-Clinical Trials
10. Later Stage VC (Series A) 22-Mar-2022 Completed Pre-Clinical Trials
9. Seed Round 01-Jan-2021 Completed Pre-Clinical Trials
8. Seed Round 31-Mar-2020 Completed Pre-Clinical Trials
7. Grant 08-Feb-2019 Completed Pre-Clinical Trials
6. Seed Round 25-Jan-2018 Completed Pre-Clinical Trials
5. Accelerator/Incubator 22-Aug-2017 Completed Startup
4. Seed Round 31-Dec-2016 Completed Startup
3. Accelerator/Incubator 01-Nov-2016 $100K Completed Startup
2. Accelerator/Incubator 09-Dec-2014 $100K Completed Startup
To view HelixNano’s complete valuation and funding history, request access »

HelixNano Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-9
Series A-8
Series A-7
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2 972,558 $0.000010 $4.18 $4.18 1x $4.18 8.04%
Series A-1 2,870,944 $0.000010 $5.22 $5.22 1x $5.22 23.72%
To view HelixNano’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

HelixNano Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 23

    Pending

  • Expiring in next 12 mo

HelixNano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023371951-A1 Ruminal and methanogen vaccines and uses thereof Pending 03-Nov-2022
US-20230383287-A1 Acetylated ribonucleic acids and uses thereof Active 04-May-2022
US-12215317-B2 Acetylated ribonucleic acids and uses thereof Active 04-May-2022
AU-2023265895-A1 Acetylated ribonucleic acids and uses thereof Pending 04-May-2022
EP-4519280-A2 Acetylated ribonucleic acids and uses thereof Pending 04-May-2022 C12N15/11
To view HelixNano’s complete patent history, request access »

HelixNano Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HelixNano Investors (48)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
BakerBridge Capital Venture Capital Minority
Champion Hill Ventures Venture Capital Minority
Dhuna Ventures Venture Capital Minority
Gaingels Venture Capital Minority
You’re viewing 5 of 48 investors. Get the full list »

Ready to get started?

Request a free trial

HelixNano FAQs

  • When was HelixNano founded?

    HelixNano was founded in 2013.

  • Where is HelixNano headquartered?

    HelixNano is headquartered in Boston, MA.

  • What is the size of HelixNano?

    HelixNano has 27 total employees.

  • What industry is HelixNano in?

    HelixNano’s primary industry is Biotechnology.

  • Is HelixNano a private or public company?

    HelixNano is a Private company.

  • What is HelixNano’s current revenue?

    The current revenue for HelixNano is .

  • How much funding has HelixNano raised over time?

    HelixNano has raised $52.5M.

  • Who are HelixNano’s investors?

    Alumni Ventures, BakerBridge Capital, Champion Hill Ventures, Dhuna Ventures, and Gaingels are 5 of 48 investors who have invested in HelixNano.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »